Uterine Fibroid Market : Worldwide Industry Analysis and New Market Opportunities Explored 2022
The Market Research Future provides detailed
analysis of “Global Uterine Fibroid
Market Research Report – forecast till 2022” by type, by indication and by
end user.
The Worldwide Uterine Fibroid Market Research Report provides detailed analysis of the
key regional market status of the Healthcare Industry. The Uterine Fibroids Market is expected to reach USD 39,993.2 Million by the end of the forecasted period and is
expected to grow at a CAGR of 3.24%.
Uterine Fibroids are the abnormal
growth that gets developed inside or on the wall of a woman’s uterus. These are
also known as leiomyoma or myomas. These are noncancerous growths that cause
symptoms such as heavy bleeding between or during the menstrual cycle, pain in
pelvis or lower back, increased menstrual cramping, swelling enlargement of the
abdomen. Increasing prevalence due to heredity and rising number of treatments
to cure this disease has fuelled the growth of this market.
Key Players for U.S. Uterine Fibroid Market:
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Key Finding
- The U.S. Uterine Fibroid Market and is
expected to reach USD 39,993.2 million by 2022.
- By Type, Intramural
Fibroids holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 14,972.5
million by 2022.
- By Treatment,
hysterectomy holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 8,042.3
million by 2022.
Uterine Fibroid Market Segments:
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
Study Objectives U.S. Uterine Fibroid Market:
provide detailed
analysis of the market structure along with forecast for the next 5 years of
the various segments and sub-segments of the U.S. Uterine Fibroid Market, provide insights about factors
affecting the market growth, analyse the market based on various factors -
price analysis, supply chain analysis, porters five force analysis etc.
To provide historical
and forecast revenue of the market segments and sub-segments with respect to
four main geographies and their countries- Americas, Europe, Asia-Pacific, and
Middle East & Africa, provide country level analysis of the market with
respect to the current market size, volume, average selling price and future
prospective, provide overview of key players and their strategic profiling in
the market, comprehensively analysing their core competencies, and drawing a
competitive landscape for the market, track and analyse competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product developments, and research and developments U.S.
Regional Analysis of U.S. Uterine Fibroid
Market:
The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.
The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.
Uterine Fibroid Market Table Of Contents:
1 Introduction
1.1.1 Prevalence Of The Uterine Fibroids In U.S. 8
2 Scope
Of Study
2.1 Research Objective 10
2.2 Assumptions & Limitations 10
2.2.1 Assumptions 10
2.2.2 Limitations 10
2.3 Market Structure 11
3 Research
Methodology
3.1 Primary Research 13
3.2 Secondary Research 13
4 U.S. Uterine
Fibroid Market
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21
…Continued
What We Provide In
Reports:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Market Research Future recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Market Research Future recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
About
Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment